NRSN — NEUROSENSE THERAPEUTICS LTD

Name: NRSN Ownership History — GTS SECURITIES LLC
Creator: 13Foresight
License: https://creativecommons.org/licenses/by/4.0/

Ownership history in GTS SECURITIES LLC · 1 quarter on record

This page tracks every 13F SEC filing in which GTS SECURITIES LLC reported a position in NEUROSENSE THERAPEUTICS LTD (NRSN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	INITIATED	35,753	—	—	0.00%	$27K	$0.77

% of Fund (quarterly) NRSN price (monthly, adj. close)

Other funds also holding NRSN

As of 2025 Q4 — sorted by position size

MEITAV INVESTMENT HOUSE LTD 3Y 7Y 0.0% Jessup Wealth Management, Inc 3Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% Pathstone Holdings, LLC 0.0% COMMONWEALTH EQUITY SERVICES, LLC 3Y 7Y 0.0% Squarepoint Ops LLC 3Y 7Y 0.0% Creative Planning 3Y 7Y 0.0% UBS Group AG 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% JONES FINANCIAL COMPANIES LLLP 3Y 7Y 0.0%

← Back to GTS SECURITIES LLC Holdings

👋

Welcome to 13Foresight!

We track 13F filings from thousands of hedge funds and alert you when your followed funds file new positions.

Keep me updated — notify me about new 13F filings from funds I follow, and occasional product updates (once a month max).